HIRONC

HIRONIC has obtained approval from the Thai Food and Drug Administration (TFDA) on the 2nd of this month for its New Doublo2.0, a cutting-edge lifting device that incorporates both HIFU (MFU) and RF technologies. This device, equipped with advanced safety features, has already reached over 20 countries worldwide.

The approval of New Doublo2.0 marks a significant step in strengthening HIRONIC's competitive edge in Thailand's medical aesthetics market. We are focused on expanding our sales and marketing efforts across Thailand and other Asian markets. Plans are underway to effectively communicate the product's capabilities through various initiatives targeted at local medical institutions and aesthetic professionals (key opinion leaders).

These initiatives include exhibitions, academic programs, and hands-on training sessions. We also plan to continuously enhance the synergy between our upcoming new products by leveraging our high brand recognition and extensive local distribution networks.

HIRONIC plans to further expand its sales and marketing initiatives to continue its leading position in Thailand, a major hub for beauty and cosmetic in Southeast Asia.

​